...
首页> 外文期刊>Hormone and Metabolic Research >Perioperative management of pheochromocytoma/paraganglioma: Is there a state of the art?
【24h】

Perioperative management of pheochromocytoma/paraganglioma: Is there a state of the art?

机译:嗜铬细胞瘤/副神经节瘤的围手术期管理:是否有最新技术?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Pheochromocytoma and paraganglioma are rare tumors of sympathetic or parasympathetic origin, presenting with a highly variable clinical picture. Rarity, as well as biological, clinical, and genetic heterogeneity are barriers to initiate prospective studies that help to establish clinical guidelines. The best management of these patients relies on the experience of a multidisciplinary team. The ultimate outcome can benefit from adequate pre-surgical evaluation and treatment as well as an accurate post-surgical follow-up. Long-term follow-up is mandatory in all patients, but is particularly important in specific familial cases such as those with an SDHB mutation where the risks of recurrence are higher. The surgical approach varies depending on tumor size, location, and surgeon's personal attitude and experience. In this paper, we summarize recommendations, based mostly on authors' and other experts' personal experiences, for the best possible management of patients prior, during and after surgery, as well as when pheochromocytoma is diagnosed during pregnancy.
机译:嗜铬细胞瘤和副神经节瘤是交感神经或副交感神经起源的罕见肿瘤,临床表现各异。稀有性以及生物学,临床和遗传异质性是开展前瞻性研究(帮助建立临床指南)的障碍。这些患者的最佳管理依赖于多学科团队的经验。最终结果可受益于充分的术前评估和治疗以及准确的术后随访。所有患者都必须进行长期随访,但在某些家族性病例中尤其重要,例如那些具有SDHB突变且复发风险较高的病例。手术方法取决于肿瘤的大小,位置以及外科医生的个人态度和经验。在本文中,我们主要根据作者和其他专家的个人经验总结建议,以期在手术前,手术中和手术后以及妊娠期间诊断为嗜铬细胞瘤时对患者进行最佳管理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号